Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL re (Q40400478)
Jump to navigation
Jump to search
scientific article published on July 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL re |
scientific article published on July 2005 |
Statements
Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro (English)
Maria Teresa Del Vecchio
Angelo Aquino
Salvatore Pasquale Prete
Kwong Y Tsang
Lucia Micheli
Cristina Nencini
Marco La Placa
Francesco Montagnani
Chiara Terrosi
Vincenzo Formica
Giorgio Giorgi
Enzo Bonmassar
Guido Francini